Corvidia Therapeutics Inc Headquarters
Looking for information about Corvidia Therapeutics Inc Headquarters? The links below have collected all the necessary data.
Corvidia - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/corvidia
- Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date 2014; Founders Matt Devalaraja, Michael Davidson, Rahul Kakkar, Ram Aiyar; Operating Status Active; Last Funding Type Convertible Note; Also Known As Corvidia Therapeutics; Legal Name Corvidia Therapeutics, Inc. Company Type For Profit; Contact Email [email protected]: 2014
Corvidia Therapeutics Inc - Company Profile and News ...
- https://www.bloomberg.com/profile/company/1379029D:US
- Dec 19, 2014 · ADDRESS. 35 Gatehouse Drive Boston, MA 02451 United States.Leader: Marc De Garidel
Corvidia Therapeutics LinkedIn
- https://www.linkedin.com/company/corvidia-therapeutics
- Corvidia Therapeutics Pharmaceuticals Waltham, MA - Massachusetts 1,143 followers A clinical stage biotechnology company developing ground-breaking therapies for cardio-renal disease.
Novo Nordisk agrees to buy Corvidia Therapeutics for $2.1bn
- https://www.pharmaceutical-business-review.com/news/novo-nordisk-acquire-corvidia/
- Novo Nordisk has agreed to acquire Corvidia Therapeutics, a portfolio company of life sciences venture capital firm Sofinnova Partners, in a deal valued at $2.1bn. Novo Nordisk headquarters, Denmark. (Credit: Novo Nordisk A/S.) Under the terms of the agreement, the Danish pharmaceutical firm will acquire all outstanding shares of Corvidia Therapeutics for an upfront payment of $725m in cash.
With $60M and a new CEO, Corvidia Therapeutics is all ...
- https://www.fiercebiotech.com/biotech/60m-and-new-ceo-corvidia-therapeutics-all-systems-go
- Apr 25, 2018 · A month after ex-Ipsen CEO Marc de Garidel took over the reins at Corvidia Therapeutics, the company reeled in a $60 million series B. The new funding will advance its lead clinical programs in ...
Our company - Ipsen
- https://www.ipsen.com/our-company/
- He was previously, for 2 years and a half, Chief Executive Officer and Director of Corvidia Therapeutics, Inc. which was sold to Novo Nordisk in July 2020. Marc de Garidel started his career with the group Eli Lilly and pursued at Amgen, from 1995 to 2010, with increasing responsibility positions in …
Have you found Corvidia Therapeutics Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.